Sort
82,697 grants matching “vaccine development”
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,473,686Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum
$1,473,611Donald Ym Leung · National Jewish Health · U19 · FY2017 · AI
RNA TRASFECTED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
$1,473,595Duke University · P01 · FY2000 · CA
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,473,388Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2009 · CA
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,473,199Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2020 · AI
Developing/Testing a Multi-level Interventions (SHIELD & IWC)
$1,472,596Sujha Subramanian · Research Triangle Institute · UH3 · FY2020 · HD
Pediatric AIDS Clinical Trials Unit
$1,472,423Children'S Memorial Hospital (Chicago) · U01 · FY2004 · AI
KSHV Persistence and Pathogenesis
$1,472,214Jae U Jung · University Of Southern California · P01 · FY2015 · CA
KSHV Persistence and Pathogenesis
$1,472,214Jae U Jung · University Of Southern California · P01 · FY2017 · CA
KSHV Persistence and Pathogenesis
$1,472,214Jae U Jung · University Of Southern California · P01 · FY2016 · CA
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
$1,472,147Joel Palefsky · University Of California, San Francisco · U54 · FY2024 · CA
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$1,471,428Mark Fredric Cotton · Stellenbosch University · U01 · FY2008 · AI
Development of a Next Generation Anthrax Vaccine, AV7909
$1,471,421Sukjoon Park · Emergent Product Development Gaithersbur · U01 · FY2008 · AI
SPECIFIC PATHOGEN FREE RHESUS MACAQUE BREEDING PROGRAM
$1,471,277Alpha Genesis, Inc. · U01 · FY2000 · AI
CANCER CHEMOTHERAPY PROGRAM PROJECT
$1,470,550Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,470,482Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
UAB CENTER FOR AIDS RESEARCH
$1,470,407University Of Alabama At Birmingham · P30 · FY2000 · AI
Immunopharmacotherapy for Mitigating Opioid Addiction
$1,470,068Kim D Janda · Scripps Research Institute, The · UH3 · FY2019 · DA
Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability
$1,469,999Beth Tebeau · Advanced Bioscience Laboratories, Inc. · N01 · FY2019 · CA
Immune correlates of protection
$1,469,877Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
$1,469,556S Munir Alam · Duke University · P01 · FY2022 · AI
VACCINE DEVELOPMENT PROGRAM
$1,469,120Center For Molecular Medicine And Immunology, Inc. · · FY2010 · Department of the Army
Institutional Career Development Core
$1,468,751Emma Anne Meagher · University Of Pennsylvania · KL2 · FY2023 · TR
Institutional Career Development Core
$1,468,751Emma Anne Meagher · University Of Pennsylvania · KL2 · FY2021 · TR
Regulatory immune cell therapy, promotion of tolerance and underlying mechanisms in NHP renal transplantation
$1,468,504Angus W Thomson · University Of Pittsburgh At Pittsburgh · U19 · FY2020 · AI